PROBLEM TO BE SOLVED : To provide use of such a composition for the prevention and/or therapy of respiratory disease, inflammatory disease, or obstructive airways disease. SOLUTION : A pharmaceutical composition comprises glycopyrrolate in combination with a β2-agonist selected from indacaterol, formoterol, vilanterol, carmoterol, and olodaterol, optionally with at least one pharmaceutically acceptable excipient. SELECTED DRAWING : None COPYRIGHT : (C)2019, JPO&INPIT